(Q37857710)

24 August 2017

title

Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria (English)

1 reference

24 August 2017

main subject

Gram-negative bacteria

0 references

antibiotic

0 references

author name string

P Keyser

1

1 reference

24 August 2017

M Elofsson

2

1 reference

24 August 2017

S Rosell

3

1 reference

24 August 2017

H Wolf-Watz

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 April 2008

1 reference

Journal of Internal Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

264

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

17-29

1 reference

Antibiotics: where did we go wrong?

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Novel antibacterials: a genomics approach to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Antibacterial resistance worldwide: causes, challenges and responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Targeting virulence: a new paradigm for antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Assembly and function of type III secretory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Yersinia type III secretion: send in the effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Supramolecular structure of the Salmonella typhimurium type III protein secretion system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

The Hrp pilus: learning from flagella

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Increased virulence of Yersinia pseudotuberculosis by two independent mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Bidirectional signaling between Yersinia and its target cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Identification of a molecular target for the Yersinia protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Antibacterial discovery and development--the failure of success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

The evolving role of natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Small molecule natural products in the discovery of therapeutic agents: the synthesis connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Background and current knowledge of Chlamydia pneumoniae and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Blinding trachoma: a disease of poverty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Chlamydia trachomatis detection and the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Salmonella pathogenicity islands encoding type III secretion systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

The invasion-associated type-III protein secretion system in Salmonella--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Typhoid and paratyphoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Targeting bacterial virulence: inhibitors of type III secretion in Yersinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Small-molecule inhibitors specifically targeting type III secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Structural analysis of a prototypical ATPase from the type III secretion system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

Antibiotic Selection May Contribute to Increases in Macrolide‐ResistantTreponema pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01941.X

10.1111/J.1365-2796.2008.01941.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference